G. Gorumlu

发表

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination

H. Atmaca, S. Uzunoğlu, U. Sanli, 2010, Molecular Biology Reports.

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer

R. Durusoy, U. Sanli, R. Uslu, 2010, Medical oncology.

Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells.

H. Atmaca, S. Uzunoğlu, U. Sanli, 2009, European cytokine network.

Bisphosphonate (Zoledronic Acid) Associated Adverse Events: Single Center Experience

U. Sanli, R. Uslu, B. Karaca, 2010 .

Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl‐2 protein level in hormone‐refractory prostate cancer cells

H. Atmaca, S. Uzunoğlu, U. Sanli, 2009, Cell biology international.

Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.

U. Sanli, R. Uslu, B. Karaca, 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol.

H. Atmaca, S. Uzunoğlu, U. Sanli, 2008, European cytokine network.

Targeting apoptosis in the hormone‐ and drug‐resistant prostate cancer cell line, DU‐145, by gossypol/zoledronic acid combination

H. Atmaca, S. Uzunoğlu, U. Sanli, 2009, Cell biology international.

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145

H. Atmaca, S. Uzunoğlu, U. Sanli, 2008, Journal of experimental & clinical cancer research : CR.

Regulation of growth factors in hormone‐ and drug‐resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

H. Atmaca, S. Uzunoğlu, U. Sanli, 2009, BJU international.

Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.

U. Sanli, R. Uslu, B. Karaca, 2008, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Apoptosis-Mediated Cytotoxic Effects of Ibandronic Acid on Hormone- and Drug-Refractory Prostate Cancer Cells and Human Breast Cancer Cells

H. Atmaca, S. Uzunoğlu, C. Sezgin, 2010, The Journal of international medical research.

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer.

R. Durusoy, U. Sanli, R. Uslu, 2010 .